Pricing Log in Create free account

Minerva Neurosciences, Inc (NERV) vs Nkarta, Inc. (NKTX)

Minerva Neurosciences, Inc and Nkarta, Inc. are both Biotechnology companies. Minerva Neurosciences, Inc and Nkarta, Inc. are of similar size ($112.5M and $109.8M). Across the 8 metrics below, Minerva Neurosciences, Inc leads on 4 and Nkarta, Inc. on 4.

Valuation

Metric NERV NKTX Biotechnology median
P/E n/m n/m 10.60
P/S n/m n/m 9.40
P/B n/m 0.53 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 0.42 0.66
EV/Sales n/m n/m 9.02
Earnings yield (1,172.31%) (89.71%) (32.88%)
Free cash flow yield (23.31%) (72.03%) (23.13%)

Profitability

Metric NERV NKTX Biotechnology median
Gross margin 0.00% 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 322.05% (38.76%) (51.96%)
Return on assets (629.71%) (29.86%) (46.06%)
Return on invested capital 0.00% (127.22%) 0.00%

Growth

Metric NERV NKTX Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) (18,347.37%) 11.88% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric NERV NKTX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 20.14 7.98 4.97
Net debt to EBITDA 5.46 2.35 1.01

Dividend

Metric NERV NKTX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric NERV NKTX Biotechnology median
Market cap 109.82m 112.45m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack